FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199724069> ?p ?o ?g. }

• W3199724069 abstract "Does lifestyle intervention consisting of an energy-restricted diet, enhancement of physical activity and motivational counseling prior to IVF improve embryo utilization rate (EUR) and cumulative live birth rate (CLBR) in women with obesity?A 6-month lifestyle intervention preceding IVF improved neither EUR nor CLBR in women with obesity in the first IVF treatment cycle where at least one oocyte was retrieved.A randomized controlled trial (RCT) evaluating the efficacy of a low caloric liquid formula diet (LCD) preceding IVF in women with obesity was unable to demonstrate an effect of LCD on embryo quality and live birth rate: in this study, only one fresh embryo transfer (ET) or, in case of freeze-all strategy, the first transfer with frozen-thawed embryos was reported. We hypothesized that any effect on embryo quality of a lifestyle intervention in women with obesity undergoing IVF treatment is better revealed by EUR and CLBR after transfer of all fresh and frozen-thawed embryos.This is a nested cohort study within an RCT, the LIFEstyle study. The original study examined whether a 6-month lifestyle intervention prior to infertility treatment in women with obesity improved live birth rate, compared to prompt infertility treatment within 24 months after randomization. In the original study between 2009 and 2012, 577 (three women withdrew informed consent) women with obesity and infertility were assigned to a lifestyle intervention followed by infertility treatment (n = 289) or to prompt infertility treatment (n = 285).Only participants from the LIFEstyle study who received IVF treatment were eligible for the current analysis. In total, 137 participants (n = 58 in the intervention group and n = 79 in the control group) started the first cycle. In 25 participants, the first cycle was cancelled prior to oocyte retrieval mostly due to poor response. Sixteen participants started a second or third consecutive cycle. The first cycle with successful oocyte retrieval was used for this analysis, resulting in analysis of 51 participants in the intervention group and 72 participants in the control group. Considering differences in embryo scoring methods and ET day strategy between IVF centers, we used EUR as a proxy for embryo quality. EUR was defined as the proportion of inseminated/injected oocytes per cycle that was transferred or cryopreserved as an embryo. Analysis was performed per cycle and per oocyte/embryo. CLBR was defined as the percentage of participants with at least one live birth from the first fresh and subsequent frozen-thawed ET(s). In addition, we calculated the Z-score for singleton neonatal birthweight and compared these outcomes between the two groups.The overall mean age was 31.6 years and the mean BMI was 35.4 ± 3.2 kg/m2 in the intervention group, and 34.9 ± 2.9 kg/m2 in the control group. The weight change at 6 months was in favor of the intervention group (mean difference in kg vs the control group: -3.14, 95% CI: -5.73 to -0.56). The median (Q25; Q75) number of oocytes retrieved was 4.00 (2.00; 8.00) in the intervention group versus 6.00 (4.00; 9.75) in the control group, and was not significantly different, as was the number of oocytes inseminated/injected (4.00 [2.00; 8.00] vs 6.00 [3.00; 8.75]), normal fertilized embryos (2.00 [0.50; 5.00] vs 3.00 [1.00; 5.00]) and the number of cryopreserved embryos (2.00 [1.25; 4.75] vs 2.00 [1.00; 4.00]). The median (Q25; Q75) EUR was 33.3% (12.5%; 60.0%) in the intervention group and 33.3% (16.7%; 50.0%) in the control group in the per cycle analysis (adjusted B: 2.7%, 95% CI: -8.6% to 14.0%). In the per oocyte/embryo analysis, in total, 280 oocytes were injected or inseminated in the intervention group, 113 were utilized (transferred or cryopreserved, EUR = 40.4%); in the control group, EUR was 30.8% (142/461). The lifestyle intervention did not significantly improve EUR (adjusted odds ratio [OR]: 1.36, 95% CI: 0.94-1.98) in the per oocyte/embryo analysis, taking into account the interdependency of the oocytes per participant. CLBR was not significantly different between the intervention group and the control group after adjusting for type of infertility (male factor and unexplained) and smoking (27.5% vs 22.2%, adjusted OR: 1.03, 95% CI: 0.43-2.47). Singleton neonatal birthweight and Z-score were not significantly different between the two groups.This study is a nested cohort study within an RCT, and no power calculation was performed. The randomization was not stratified for indicated treatment, and although we corrected our analyses for baseline differences, there may be residual confounding. The limited absolute weight loss and the short duration of the lifestyle intervention might be insufficient to affect EUR and CLBR.Our data do not support the hypothesis of a beneficial short-term effect of lifestyle intervention on EUR and CLBR after IVF in women with obesity, although more studies are needed as there may be a potential clinically relevant effect on EUR.The study was supported by a grant from ZonMw, the Dutch Organization for Health Research and Development (50-50110-96-518). A.H. has received an unrestricted educational grant from Ferring pharmaceuticals BV, The Netherlands. B.W.J.M. is supported by an NHMRC Investigator grant (GNT1176437). B.W.J.M. reports consultancy for Guerbet, has been a member of the ObsEva advisory board and holds Stock options for ObsEva. B.W.J.M. has received research funding from Guerbet, Ferring and Merck. F.J.M.B. reports personal fees from membership of the external advisory board for Merck Serono and a research support grant from Merck Serono, outside the submitted work.The LIFEstyle RCT was registered at the Dutch trial registry (NTR 1530). https://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1530." @default.
• W3199724069 created "2021-09-27" @default.
• W3199724069 creator A5005254575 @default.
• W3199724069 creator A5014311522 @default.
• W3199724069 creator A5026853664 @default.
• W3199724069 creator A5038307477 @default.
• W3199724069 creator A5052123323 @default.
• W3199724069 creator A5073413004 @default.
• W3199724069 creator A5075304993 @default.
• W3199724069 creator A5077107849 @default.
• W3199724069 creator A5077604971 @default.
• W3199724069 creator A5082503529 @default.
• W3199724069 creator A5084970322 @default.
• W3199724069 creator A5090595139 @default.
• W3199724069 creator A5090795384 @default.
• W3199724069 creator A5091296628 @default.
• W3199724069 date "2021-08-07" @default.
• W3199724069 modified "2023-09-26" @default.
• W3199724069 title "Lifestyle intervention prior to IVF does not improve embryo utilization rate and cumulative live birth rate in women with obesity: a nested cohort study" @default.
• W3199724069 cites W191754116 @default.
• W3199724069 cites W1987984705 @default.
• W3199724069 cites W1995863801 @default.
• W3199724069 cites W2024892781 @default.
• W3199724069 cites W2035163077 @default.
• W3199724069 cites W2042934567 @default.
• W3199724069 cites W2043927249 @default.
• W3199724069 cites W2066738866 @default.
• W3199724069 cites W2094044631 @default.
• W3199724069 cites W2098199441 @default.
• W3199724069 cites W2104719592 @default.
• W3199724069 cites W2116192451 @default.
• W3199724069 cites W2117082199 @default.
• W3199724069 cites W2119716682 @default.
• W3199724069 cites W2122656129 @default.
• W3199724069 cites W2124432711 @default.
• W3199724069 cites W2125558713 @default.
• W3199724069 cites W2145608252 @default.
• W3199724069 cites W2152189545 @default.
• W3199724069 cites W2155041305 @default.
• W3199724069 cites W2165753825 @default.
• W3199724069 cites W2170676435 @default.
• W3199724069 cites W2172064348 @default.
• W3199724069 cites W2182278065 @default.
• W3199724069 cites W2255765787 @default.
• W3199724069 cites W2404662288 @default.
• W3199724069 cites W2521737428 @default.
• W3199724069 cites W2549080304 @default.
• W3199724069 cites W2729389999 @default.
• W3199724069 cites W2735847101 @default.
• W3199724069 cites W2889915354 @default.
• W3199724069 cites W2900128024 @default.
• W3199724069 cites W2927405476 @default.
• W3199724069 cites W3093577184 @default.
• W3199724069 cites W4211163429 @default.
• W3199724069 doi "https://doi.org/10.1093/hropen/hoab032" @default.
• W3199724069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8452483" @default.
• W3199724069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34557597" @default.
• W3199724069 hasPublicationYear "2021" @default.
• W3199724069 type Work @default.
• W3199724069 sameAs 3199724069 @default.
• W3199724069 citedByCount "5" @default.
• W3199724069 countsByYear W31997240692022 @default.
• W3199724069 countsByYear W31997240692023 @default.
• W3199724069 crossrefType "journal-article" @default.
• W3199724069 hasAuthorship W3199724069A5005254575 @default.
• W3199724069 hasAuthorship W3199724069A5014311522 @default.
• W3199724069 hasAuthorship W3199724069A5026853664 @default.
• W3199724069 hasAuthorship W3199724069A5038307477 @default.
• W3199724069 hasAuthorship W3199724069A5052123323 @default.
• W3199724069 hasAuthorship W3199724069A5073413004 @default.
• W3199724069 hasAuthorship W3199724069A5075304993 @default.
• W3199724069 hasAuthorship W3199724069A5077107849 @default.
• W3199724069 hasAuthorship W3199724069A5077604971 @default.
• W3199724069 hasAuthorship W3199724069A5082503529 @default.
• W3199724069 hasAuthorship W3199724069A5084970322 @default.
• W3199724069 hasAuthorship W3199724069A5090595139 @default.
• W3199724069 hasAuthorship W3199724069A5090795384 @default.
• W3199724069 hasAuthorship W3199724069A5091296628 @default.
• W3199724069 hasBestOaLocation W31997240691 @default.
• W3199724069 hasConcept C126322002 @default.
• W3199724069 hasConcept C131872663 @default.
• W3199724069 hasConcept C160099875 @default.
• W3199724069 hasConcept C168563851 @default.
• W3199724069 hasConcept C2776537878 @default.
• W3199724069 hasConcept C2777688143 @default.
• W3199724069 hasConcept C2778279030 @default.
• W3199724069 hasConcept C2779234561 @default.
• W3199724069 hasConcept C29456083 @default.
• W3199724069 hasConcept C511355011 @default.
• W3199724069 hasConcept C54355233 @default.
• W3199724069 hasConcept C71924100 @default.
• W3199724069 hasConcept C86803240 @default.
• W3199724069 hasConceptScore W3199724069C126322002 @default.
• W3199724069 hasConceptScore W3199724069C131872663 @default.
• W3199724069 hasConceptScore W3199724069C160099875 @default.
• W3199724069 hasConceptScore W3199724069C168563851 @default.
• W3199724069 hasConceptScore W3199724069C2776537878 @default.
• W3199724069 hasConceptScore W3199724069C2777688143 @default.
• W3199724069 hasConceptScore W3199724069C2778279030 @default.
• W3199724069 hasConceptScore W3199724069C2779234561 @default.

• next